Tetrabenazine
Tetrabenazine is a prescription medication that acts as a vesicular monoamine transporter 2 inhibitor, used to treat involuntary movements in conditions like Huntington's disease. It comes as oral tablets in 12.5 mg and 25 mg strengths, manufactured by Dr. Reddy's Laboratories Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tetrabenazine is a prescription medication that acts as a vesicular monoamine transporter 2 inhibitor, used to treat involuntary movements in conditions like Huntington's disease. It comes as oral tablets in 12.5 mg and 25 mg strengths, manufactured by Dr. Reddy's Laboratories Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tetrabenazine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tetrabenazine — ANDA 213621 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213621"
}
]
|
| identifier | ANDA213621 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"fda",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tetrabenazine |
